Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec;38(6):1099-1101.
doi: 10.1007/s10557-024-07625-6. Epub 2024 Sep 5.

Does One Size Fits All?

Vanessa Roldan  1 , Juan Jose Badimon  2
Affiliations
Editorial

Does One Size Fits All?

Vanessa Roldan et al. Cardiovasc Drugs Ther. 2024 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.

References

    1. De Caterina R, Husted S, Wallentin L, et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost. 2013;110:1087–107. https://doi.org/10.1160/TH13-06-0443 . - DOI - PubMed
    1. Schwarz UI, Ritchie MD, Bradford Y, et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med. 2008;358:999–1008. https://doi.org/10.1056/NEJMoa0708078 . - DOI - PubMed - PMC
    1. Kawai VK, Cunningham A, Vear SI, et al. Genotype and risk of major bleeding during warfarin treatment. Pharmacogenomics. 2014;15(16):1973–83. https://doi.org/10.2217/pgs.14.153 . - DOI - PubMed
    1. Gómez-Outes A, Lagunar-Ruíz J, Terleira-Fernández AI, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Causes of death in anticoagulated patients with atrial fibrillation. JACC. 2016;68(23):2508–21. https://doi.org/10.1016/j.jacc.2016.09.944 . - DOI - PubMed
    1. Mueck W, Kubitza D, Becka M. Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects. Brit J Clinical Pharma. 2013;76(3):455–66. https://doi.org/10.1111/bcp.12075 . - DOI

Publication types

LinkOut - more resources